---
figid: PMC9153257__i2590-017X-4-2-79-f01
figtitle: Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers?
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9153257
filename: i2590-017X-4-2-79-f01.jpg
figlink: /pmc/articles/PMC9153257/figure/i2590-017X-4-2-79-f01/
number: F1
caption: 'Interleukin-6 (IL-6) signaling pathways. In the classical IL-6 signaling
  pathway, induced by binding of IL-6 to membrane-bound IL-6R, the activation of JAK/STAT,
  AKT, and MAPK pathways determines the release of cytokines and consequent feedback
  inhibition through SOCS. In the trans-signaling pathway, in which the IL-6/IL-6R
  complex activates gp130, there is a shift toward greater JAK/STAT signaling than
  MAPK signaling through suppression of SOCS, leading to greater transcription of
  cytokines and a proinflammatory state. AKT: protein kinase B; ERK: extracellular
  regulated kinases; gp130: glycoprotein 130; IL-6: interleukin 6; IL-6R: interleukin
  6 receptor; JAK: Janus kinase; MAPK: mitogen-activated protein kinase; NFkB: nuclear
  factor kappa B; PI3K: phosphatidylinositol 3-kinases; sIL-6R: soluble IL-6 receptor;
  SOCS: suppressor of cytokine signalling; STAT: signal transducer and activator of
  transcription.'
papertitle: Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers?.
reftext: Aldo Venuti, et al. J Immunother Precis Oncol. 2021 May;4(2):79-85.
year: '2021'
doi: 10.36401/JIPO-20-27
journal_title: Journal of Immunotherapy and Precision Oncology
journal_nlm_ta: J Immunother Precis Oncol
publisher_name: Innovative Healthcare Institute
keywords: interleukin-6 (IL-6) | coronavirus-associated cancers | SARS-CoV-2
automl_pathway: 0.9541569
figid_alias: PMC9153257__F1
figtype: Figure
redirect_from: /figures/PMC9153257__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9153257__i2590-017X-4-2-79-f01.html
  '@type': Dataset
  description: 'Interleukin-6 (IL-6) signaling pathways. In the classical IL-6 signaling
    pathway, induced by binding of IL-6 to membrane-bound IL-6R, the activation of
    JAK/STAT, AKT, and MAPK pathways determines the release of cytokines and consequent
    feedback inhibition through SOCS. In the trans-signaling pathway, in which the
    IL-6/IL-6R complex activates gp130, there is a shift toward greater JAK/STAT signaling
    than MAPK signaling through suppression of SOCS, leading to greater transcription
    of cytokines and a proinflammatory state. AKT: protein kinase B; ERK: extracellular
    regulated kinases; gp130: glycoprotein 130; IL-6: interleukin 6; IL-6R: interleukin
    6 receptor; JAK: Janus kinase; MAPK: mitogen-activated protein kinase; NFkB: nuclear
    factor kappa B; PI3K: phosphatidylinositol 3-kinases; sIL-6R: soluble IL-6 receptor;
    SOCS: suppressor of cytokine signalling; STAT: signal transducer and activator
    of transcription.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Socs16D
  - Socs36E
  - Socs44A
  - hop
  - bsk
  - Stat92E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Dif
  - dl
  - Rel
  - MKP-4
  - p38b
  - rl
  - Erk7
  - IL6
  - IL6ST
  - NM
  - LRPPRC
  - IL6R
  - CISH
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
---
